| Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock D Annane, V Sébille, C Charpentier, PE Bollaert, B François, JM Korach, ... Jama 288 (7), 862-871, 2002 | 3749 | 2002 |
| A randomized trial of glutamine and antioxidants in critically ill patients D Heyland, J Muscedere, PE Wischmeyer, D Cook, G Jones, M Albert, ... New England Journal of Medicine 368 (16), 1489-1497, 2013 | 907* | 2013 |
| Decontamination of the digestive tract and oropharynx in ICU patients A De Smet, J Kluytmans, BS Cooper, EM Mascini, RFJ Benus, ... New England Journal of Medicine 360 (1), 20-31, 2009 | 833 | 2009 |
| Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line JG Zijlstra, EGE de Vries, NH Mulder Cancer Research 47 (7), 1780-1784, 1987 | 320 | 1987 |
| Morbidity in hospitalized patients receiving human albumin: a meta-analysis of randomized, controlled trials JL Vincent, RJ Navickis, MM Wilkes Critical care medicine 32 (10), 2029-2038, 2004 | 252 | 2004 |
| Leukocyte activation in sepsis; correlations with disease state and mortality ACM Kobold, JE Tulleken, JG Zijlstra, W Sluiter, J Hermans, ... Intensive care medicine 26 (7), 883-892, 2000 | 238 | 2000 |
| Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature S Meijering, AM Corstjens, JE Tulleken, JHJM Meertens, JG Zijlstra, ... Critical Care 10 (1), 1-7, 2006 | 223 | 2006 |
| Accuracy and feasibility of point-of-care and continuous blood glucose analysis in critically ill ICU patients AM Corstjens, JJM Ligtenberg, ICC van der Horst, R Spanjersberg, ... Critical Care 10 (5), 1-7, 2006 | 193 | 2006 |
| Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line S de Jong, JG Zijlstra, EGE de Vries, NH Mulder Cancer research 50 (2), 304-309, 1990 | 186 | 1990 |
| Quality of interhospital transport of critically ill patients: a prospective audit JJM Ligtenberg, LG Arnold, Y Stienstra, TS van der Werf, JHJM Meertens, ... Critical Care 9 (4), 1-6, 2005 | 180 | 2005 |
| Nocturnal non-invasive ventilation in addition to rehabilitation in hypercapnic patients with COPD ML Duiverman, JB Wempe, G Bladder, DF Jansen, HAM Kerstjens, ... Thorax 63 (12), 1052-1057, 2008 | 174 | 2008 |
| Increased circulating endothelial progenitor cells in septic patients: correlation with survival N Rafat, C Hanusch, PT Brinkkoetter, J Schulte, J Brade, JG Zijlstra, ... Critical care medicine 35 (7), 1677-1684, 2007 | 159 | 2007 |
| Blunted rise in platelet count in critically ill patients is associated with worse outcome MWN Nijsten, HJ ten Duis, JG Zijlstra, RJ Porte, JH Zwaveling, JC Paling Critical care medicine 28 (12), 3843-3846, 2000 | 158 | 2000 |
| Two-year home-based nocturnal noninvasive ventilation added to rehabilitation in chronic obstructive pulmonary disease patients: a randomized controlled trial ML Duiverman, JB Wempe, G Bladder, JM Vonk, JG Zijlstra, ... Respiratory research 12 (1), 1-10, 2011 | 147 | 2011 |
| Quality of interhospital transport of the critically ill: impact of a Mobile Intensive Care Unit with a specialized retrieval team JS Wiegersma, JM Droogh, JG Zijlstra, J Fokkema, JJM Ligtenberg Critical care 15 (1), 1-8, 2011 | 145 | 2011 |
| Bench-to-bedside review: Angiopoietin signalling in critical illness–a future target? M van Meurs, P Kümpers, JJM Ligtenberg, JHJM Meertens, G Molema, ... Critical care 13 (2), 1-13, 2009 | 144 | 2009 |
| Organophosphorus pesticide poisoning: cases and developments H Aardema, JH Meertens, JJ Ligtenberg, OM Peters-Polman, JE Tulleken, ... Neth J Med 66 (4), 149-53, 2008 | 144 | 2008 |
| P-glycoprotein expression and DNA topoisomerase I and II activity in benign tumors of the ovary and in malignant tumors of the ovary, before and after platinum/cyclophosphamide … AGJ van der Zee, H Hollema, S de Jong, H Boonstra, A Gouw, ... Cancer research 51 (21), 5915-5920, 1991 | 142 | 1991 |
| Transferring the critically ill patient: are we there yet? JM Droogh, M Smit, AR Absalom, JJM Ligtenberg, JG Zijlstra Critical Care 19 (1), 1-7, 2015 | 138 | 2015 |
| Suppression of the clinical and cytokine response to endotoxin by RWJ‐67657, a p38 mitogen‐activated protein‐kinase inhibitor, in healthy human volunteers JW Fijen, JG Zijlstra, P De Boer, R Spanjersberg, JW Cohen Tervaert, ... Clinical & Experimental Immunology 124 (1), 16-20, 2001 | 132 | 2001 |
Matijs van meursAnesthesiologist- Intensivist MD PhD, University Medical Center Groningen, Department of CriticalVerified email at umcg.nl
